MLICM
TDOC icon

Metropolitan Life Insurance Company (MetLife)’s Teladoc Health TDOC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,013
Closed -$277K – 2653
2021
Q4 		$277K Buy
3,013
+8
+0.3% +$956 ﹤0.01% 1791
2021
Q3 		$381K Sell
3,005
-28
-0.9% -$4.08K 0.01% 1631
2021
Q2 		$504K Sell
3,033
-4,420
-59% -$716K 0.01% 1515
2021
Q1 		$1.35M Sell
7,453
-323
-4% -$74.9K 0.02% 748
2020
Q4 		$1.55M Buy
7,776
+2,618
+51% +$532K 0.02% 600
2020
Q3 		$1.13M Sell
5,158
-292
-5% -$61.8K 0.02% 668
2020
Q2 		$1.04M Sell
5,450
-16,024
-75% -$2.81M 0.02% 720
2020
Q1 		$3.33M Sell
21,474
-500
-2% -$58.2K 0.07% 236
2019
Q4 		$1.84M Sell
21,974
-1,296
-6% -$98.6K 0.03% 582
2019
Q3 		$1.58M Buy
23,270
+1,350
+6% +$88.8K 0.03% 617
2019
Q2 		$1.46M Buy
21,920
+362
+2% +$21.1K 0.02% 678
2019
Q1 		$1.2M Sell
21,558
-241
-1% -$14.7K 0.02% 781
2018
Q4 		$1.08M Buy
21,799
+166
+0.8% +$10.2K 0.02% 765
2018
Q3 		$1.87M Buy
21,633
+1,588
+8% +$113K 0.03% 566
2018
Q2 		$1.16M Buy
20,045
+2,228
+13% +$109K 0.02% 845
2018
Q1 		$718K Buy
17,817
+302
+2% +$11.4K 0.01% 1065
2017
Q4 		$610K Sell
17,515
-19,244
-52% -$639K 0.01% 1150
2017
Q3 		$1.22M Hold
36,759
– – 0.01% 1141
2017
Q2 		$1.28M Buy
36,759
+20,015
+120% +$583K 0.01% 1112
2017
Q1 		$419K Hold
16,744
– – ﹤0.01% 1775
2016
Q4 		$276K Hold
16,744
– – ﹤0.01% 2146
2016
Q3 		$307K Hold
16,744
– – ﹤0.01% 2051
2016
Q2 		$268K Buy
+16,744
New +$195K ﹤0.01% 2123

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TDOC Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,013 shares — an estimated $277K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TDOC in Q2 2016 and held it in 23 quarters. The position peaked at $3.33M in Q1 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,013 Teladoc Health shares in Q1 2022, an estimated $277K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Teladoc Health in Q2 2016 and held it in 23 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Teladoc Health position peaked at $3.33M in Q1 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.